↓ Skip to main content

Dove Medical Press

DNA Methylation Level of Transcription Factor Binding Site in the Promoter Region of Acyl-CoA Synthetase Family Member 3 (ACSF3) in Saudi Autistic Children

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, February 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
18 Mendeley
Title
DNA Methylation Level of Transcription Factor Binding Site in the Promoter Region of Acyl-CoA Synthetase Family Member 3 (ACSF3) in Saudi Autistic Children
Published in
Pharmacogenomics and Personalized Medicine, February 2022
DOI 10.2147/pgpm.s346187
Pubmed ID
Authors

Khloud Algothmi, Amal Alqurashi, Aisha Alrofaidi, Mona Alharbi, Reem Farsi, Najla Alburae, Magdah Ganash, Sheren Azhari, Fatemah Basingab, Asma Almuhammadi, Amany Alqosaibi, Heba Alkhatabi, Aisha Elaimi, Mohammed Jan, Hesham Aldhalaan, Aziza Alrafiah, Safiah Alhazmi

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 22%
Student > Bachelor 2 11%
Professor 1 6%
Student > Doctoral Student 1 6%
Student > Master 1 6%
Other 1 6%
Unknown 8 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 11%
Medicine and Dentistry 2 11%
Nursing and Health Professions 2 11%
Psychology 2 11%
Arts and Humanities 1 6%
Other 1 6%
Unknown 8 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2022.
All research outputs
#20,964,263
of 25,748,735 outputs
Outputs from Pharmacogenomics and Personalized Medicine
#1
of 1 outputs
Outputs of similar age
#392,704
of 521,128 outputs
Outputs of similar age from Pharmacogenomics and Personalized Medicine
#1
of 1 outputs
Altmetric has tracked 25,748,735 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1 research outputs from this source. They receive a mean Attention Score of 0.5. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 521,128 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them